PPSRX
Price
$18.81
Change
+$0.14 (+0.75%)
Updated
May 8 closing price
Net Assets
3.49B
VIVIX
Price
$65.64
Change
+$0.25 (+0.38%)
Updated
May 8 closing price
Net Assets
183.65B
Ad is loading...

PPSRX vs VIVIX

Header iconPPSRX vs VIVIX Comparison
Open Charts PPSRX vs VIVIXBanner chart's image
Principal Large Cap Value III R5
Price$18.81
Change+$0.14 (+0.75%)
VolumeN/A
Net Assets3.49B
Vanguard Value Index I
Price$65.64
Change+$0.25 (+0.38%)
VolumeN/A
Net Assets183.65B
PPSRX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PPSRX vs. VIVIX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PPSRX is a Buy and VIVIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. PPSRX (3.49B). VIVIX pays higher dividends than PPSRX: VIVIX (2.35) vs PPSRX (1.13). PPSRX was incepted earlier than VIVIX: PPSRX (24 years) vs VIVIX (27 years). PPSRX (0.96) is less costly to investors than VIVIX (0.04). PPSRX is a more actively managed with annual turnover of: 41.10 vs. VIVIX (9.00). PPSRX has a lower initial minimum investment than VIVIX: PPSRX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 5.12 vs. PPSRX (-3.03). VIVIX return over 5 years is better than : 72.19 vs. PPSRX (39.72).
PPSRXVIVIXPPSRX / VIVIX
Total Expense Ratio0.940.042,350%
Annual Report Gross Expense Ratio0.960.042,400%
Fund Existence24 years27 years-
Gain YTD-3.013-0.942320%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.49B184B2%
Annual Yield % from dividends1.132.3548%
Returns for 1 year-3.035.12-59%
Returns for 3 years4.4920.6622%
Returns for 5 years39.7272.1955%
Returns for 10 years29.6096.2131%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OISVX13.090.19
+1.47%
Optimum Small-Mid Cap Value Instl
FCCVX33.26N/A
N/A
Fidelity Advisor Convertible Secs C
MFRJX55.38N/A
N/A
MFS Research R4
HLFNX28.62N/A
N/A
Hennessy Large Cap Financial Investor
BGPTX11.30N/A
N/A
Baillie Gifford Developed EAFE All Cap 2